InvestorsHub Logo
Followers 0
Posts 484
Boards Moderated 0
Alias Born 10/10/2014

Re: None

Tuesday, 05/23/2017 12:45:32 PM

Tuesday, May 23, 2017 12:45:32 PM

Post# of 2099
MIXiii Biomed 2017 Program

Prof. Dror Harats, MD, CEO, VBL Therapeutics: "Viral Immune Oncology"

http://kenes-exhibitions.com/biomed2017/program-overview/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News